Literature DB >> 3358881

The influence of beta-adrenoceptor blockers with and without intrinsic sympathomimetic activity on heart rate, arrhythmias and ST-T segments, using ambulatory electrocardiography.

R J Northcote1, D Ballantyne.   

Abstract

1. Ambulatory electrocardiography was used to compare the effects of propranolol and pindolol on symptoms, heart rate, arrhythmias and ST segments. Seventeen males (mean age 54 years) with a diagnosis of chronic stable angina pectoris (New York Heart Association Class II-III) were studied. Patients were treated on a double-blind cross-over basis with propranolol 80 mg three times daily or pindolol 5 mg three times daily for 14 days each. During the last 48 h of each treatment period ambulatory electrocardiography was performed. 2. Propranolol resulted in a significantly lower mean hourly, mean 24 h and minimum heart rate. Likewise propranolol caused a lower mean daytime and nocturnal heart rate. There was no significant difference in the frequency of angina between the treatments. The number of episodes of ST segment depression was not significantly different between the two drugs, although there was a trend in favour of propranolol. 3. Both the mean 24 h ST level and the maximum ST segment depression were lower during treatment with pindolol. Propranolol was associated with a total of 117 nocturnal pauses or episodes of asystole ranging in length from 1.5 to 2.8 s. During treatment with pindolol only one such period occurred. The number of premature ventricular contractions occurring during treatment with pindolol (1316 beats) was less than on propranolol (2010) and the mean hourly frequency of premature ventricular contractions was significantly lower during pindolol administration. 4. Pindolol is not significantly different from propranolol in the control of symptomatic and asymptomatic myocardial ischaemia and is associated with fewer premature ventricular contractions. However, there is no advantage in using pindolol in chronic stable angina.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3358881      PMCID: PMC1386472          DOI: 10.1111/j.1365-2125.1988.tb03289.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  19 in total

1.  Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 6. A comparison of pindolol and propranolol in treatment of patients with angina pectoris. The role of intrinsic sympathomimetic activity.

Authors:  W Frishman; J Kostis; J Strom; M Hossler; U Elkayam; S Goldner; R Silverman; R Davis; J Weinstein; E Sonnenblick
Journal:  Am Heart J       Date:  1979-10       Impact factor: 4.749

Review 2.  Partial agonist activity of beta-adrenergic blocking agents and cardiac performance: a review.

Authors:  A Reale; M Motolese
Journal:  Eur Heart J       Date:  1981-06       Impact factor: 29.983

3.  Limitations of routine long-term electrocardiographic monitoring to assess ventricular ectopic frequency.

Authors:  J Morganroth; E L Michelson; L N Horowitz; M E Josephson; A S Pearlman; W B Dunkman
Journal:  Circulation       Date:  1978-09       Impact factor: 29.690

4.  Randomized double-blind study of pindolol in patients with stable angina pectoris.

Authors:  W E Harston; G C Friesinger
Journal:  Am Heart J       Date:  1982-08       Impact factor: 4.749

5.  Mechanisms of nocturnal angina pectoris: importance of increased myocardial oxygen demand in patients with severe coronary artery disease.

Authors:  A A Quyyumi; C A Wright; L J Mockus; K M Fox
Journal:  Lancet       Date:  1984-06-02       Impact factor: 79.321

6.  Effect of partial agonist activity in beta blockers in severe angina pectoris: a double blind comparison of pindolol and atenolol.

Authors:  A A Quyyumi; C Wright; L Mockus; K M Fox
Journal:  Br Med J (Clin Res Ed)       Date:  1984-10-13

7.  Role of heart rate in pathophysiology of chronic stable angina.

Authors:  S Chierchia; A Gallino; G Smith; J Deanfield; M Morgan; M Croom; A Maseri
Journal:  Lancet       Date:  1984-12-15       Impact factor: 79.321

8.  Treatment of angina pectoris with pindolol: the significance of intrinsic sympathomimetic activity of beta blockers.

Authors:  J B Kostis; W Frishman; M H Hosler; N L Thorsen; L Gonasun; J Weinstein
Journal:  Am Heart J       Date:  1982-08       Impact factor: 4.749

9.  Effects of beta-adrenergic blockade with pindolol versus placebo in coronary patients with stable angina pectoris.

Authors:  E M Dwyer; A J Pepe; B H Pinkernell
Journal:  Am Heart J       Date:  1982-05       Impact factor: 4.749

10.  Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.

Authors:  U Thadani; C Davidson; W Singleton; S H Taylor
Journal:  Am J Med       Date:  1980-02       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.